- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02263534
Comparing Minisling to Tension Free Vaginal Tape in Mangement of Stress Urinary Incontinence
September 18, 2018 updated by: Ahmed Reda, Ain Shams University
Randomized Controlled Trial Comparing Minisling to Tension Free Vaginal Tape in Mangement of Stress Urinary Incontinence
Based on previous studies the single incision minisling is an easy less invasive procedure with fewer complications and cure rate similar to conventional midurethral slings in the treatment of female stress urinary incontinence.
The aim of this study is to test the hypothesis that the single incision mini-sling placed in the "U" position is not inferior to TVT in this patient population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Ain Shams University, Maternity Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients with urodynamic stress urinary incontinence, with or without pelvic organ prolapse
Exclusion Criteria:
- Patients with overactive bladder on urodynamic study.
- Patients with voiding dysfunction.
- Patients with intrinsic sphincteric deficiency.
- Patients with previous anti-incontinence surgery.
- Patients on anti-coagulant therapy.
- Immune-compromised patients (DM, patients on corticosteroids treatment).
- Refusal of surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: minisling
patients in this arm will undergo single incision minisling
|
midline incision of the vagina at midurethral level dissection of the vagina from perivesical fascia insertion of the tape (polypropylene macropore mesh tape) in the retropubic direction with its end grasped with an artery forceps till level of perineal membrane closure of the vagina 2 sham incisions if the skin only will be made at suprapubic to maintain blindness posterior colpoperneorraphy will be carried out if needed
|
|
Sham Comparator: tension free vaginal tape
patients in this arm will undergo tension free vaginal tape
|
midline incision of the vagina at midurethral level dissection of the vagina from perivesical fascia insertion of the tape (polypropylene macropore mesh tape) with the applicators in the retropubic direction and 2 skin incision will be made supra pubic through which the applicators will be passed and removed and the tape will be cut at level just below the skin closure of the vagina posterior colpoperneorraphy will be carried out if needed
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
objective cure rate of urinary incontinence at 12 months after surgery
Time Frame: 12 months
|
Objective cure is indicated by a negative stress test and the absence of any additional surgical or nonsurgical treatment for stress urinary incontinence
|
12 months
|
|
subjective cure rate of urinary incontinence at 12 months after surgery
Time Frame: 12 months
|
subjective cure is indicated by an Incontinence Severity Index score of 0 and the absence of any additional surgical or nonsurgical treatment for stress urinary incontinence
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with short- term complications
Time Frame: 12 months
|
short-term complications (less than 6 weeks): post-operative pain, urinary retention, denovo urgency and wound sepsis
|
12 months
|
|
Number of participants with long-term complications
Time Frame: 12 months
|
long-term complications: erosion, dyspareunia and recurrence
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: ahmed reda, M.Sc, AIN shams university
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 10, 2014
Primary Completion (Actual)
June 1, 2017
Study Completion (Actual)
October 1, 2017
Study Registration Dates
First Submitted
August 20, 2014
First Submitted That Met QC Criteria
October 10, 2014
First Posted (Estimate)
October 13, 2014
Study Record Updates
Last Update Posted (Actual)
September 19, 2018
Last Update Submitted That Met QC Criteria
September 18, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SIMS001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress Urinary Incontinence
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
University Magna GraeciaUnknownStress Urinary IncontinenceItaly
-
University of California, IrvineWithdrawnStress Urinary IncontinenceUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Stress IncontinenceUnited States
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
-
KYU-SUNG LEEFurun MedicalCompletedFemale Stress Urinary IncontinenceKorea, Republic of
Clinical Trials on single incision minisling
-
Michigan Institution of Women's Health PCActive, not recruitingStress Urinary IncontinenceUnited States
-
University of Texas Southwestern Medical CenterCompleted
-
Western Galilee Hospital-NahariyaCompletedPost Operative Complications | Intra-operative ComplicationsIsrael
-
Maltepe UniversityCompletedStress Urinary IncontinenceTurkey
-
Coloplast A/STerminatedUrinary Incontinence, StressSpain, Belgium, France, Germany, Italy
-
Universidad Autonoma de MadridCompleted
-
Hvidovre University HospitalCompletedAdenocarcinoma | Rectal CancerDenmark
-
University of British ColumbiaCompleted
-
University of California, San DiegoCompletedAppendicitis | Cholelithiasis | Malignant HypertensionUnited States
-
Children Hospital FaisalabadRecruitingUndescended TestisPakistan